In the BioHarmony Drug Report Database
Fesoterodine
Toviaz (fesoterodine) is a small molecule pharmaceutical. Fesoterodine was first approved as Toviaz on 2007-04-20. It is used to treat urge urinary incontinence in the USA. It has been approved in Europe to treat overactive urinary bladder. Toviaz’s patents are valid until 2027-06-07 (FDA).
Trade Name
|
Toviaz |
|---|---|
Common Name
|
fesoterodine |
ChEMBL ID
|
CHEMBL1201764 |
Indication
|
overactive urinary bladder, urge urinary incontinence |
Drug Class
|
Image (chem structure or protein)